Literature DB >> 467773

Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice.

A E Bogden, P M Haskell, D J LePage, D E Kelton, W R Cobb, H J Esber.   

Abstract

The subrenal capsule technique proved effective in demonstrating that the growth of human tumors in normal, immunocompetent animals for 6 days was quantifiable in ocular micrometer units. Positive growth was demonstrable not only with human tumors that had been established in serial transplantation in athymic nude mouse hosts, but also with primary surgical explants. Growth rates of transplantation-established xenograft systems were similar whether implanted in athymic nude or in normal immunocompetent animals indicating that the 6-day time-frame successfully evades growth inhibitory effects of immunologic origin. Immunosuppression with a single dose of cyclophosphamide did not appear to affect growth rate, but permitted the tumors to grow larger extending the time to reach peak size. Significantly, xenografts of primary surgical explants showed positive growth more frequently in 6 days (82%) in the immunocompetent animal than in 11 days (30%) in the immunodeficient athymic nude mouse.

Entities:  

Mesh:

Year:  1979        PMID: 467773     DOI: 10.1159/000162947

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  23 in total

1.  A novel method for implantation of LNCaP prostate tumor cells under the renal capsule.

Authors:  R M Adam; A Orsola; M R Freeman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-06       Impact factor: 2.416

2.  Spontaneous acquisition of tumorigenicity and invasiveness by mouse lens explant cells during culture in vitro.

Authors:  L Messiaen; S Qian; G De Bruyne; E Boghaert; T Moens; M Rabaey; F Van Roy; M Mareel
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

3.  Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo.

Authors:  A E Stephen; P T Masiakos; D L Segev; J P Vacanti; P K Donahoe; D T MacLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  The usefulness of cyclophosphamide pretreatment for subrenal capsule assay against human esophageal cancer.

Authors:  M Terashima; K Ikeda; S Kawamura; C Maesawa; K Ishida; M Sato; K Saito
Journal:  Jpn J Surg       Date:  1991-03

5.  The anti-tumor effect of in vitro tumor-stimulated autologous peripheral blood lymphocytes measured by the subrenal capsule assay.

Authors:  C Kürten; R Kau; H Kumazawa; P Koldovsky
Journal:  Arch Otorhinolaryngol       Date:  1989

6.  Responses of tumour cell lines implanted onto the chorioallantoic membrane of chick embryo to anticancer agents in combination with hyperthermia.

Authors:  T Uchibayashi; M Egawa; K Nakajima; H Hisazumi; M Tanaka; Y Endo; T Sasaki
Journal:  Urol Res       Date:  1992

7.  Chemotherapy responsiveness of human breast tumors in the 6-day subrenal capsule assay: an update.

Authors:  A E Bogden; M E Costanza; S D Reich; T W Griffin; W R Cobb
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

8.  Immunohistopathological characterizatin of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) xenograft.

Authors:  M V Croce; A G Colussi; M G De Bravo; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

9.  Establishment of fluorescent lung carcinoma metastasis model and its real-time microscopic detection in SCID mice.

Authors:  Ming-Shyan Huang; Tzu-Jou Wang; Chung-Ling Liang; Huey-Mei Huang; I-Chi Yang; Hua Yi-Jan; Michael Hsiao
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  Brain tumor growth and response to chemotherapy in the subrenal capsule assay.

Authors:  M Weizsäcker; A Nagamune; K Rathmer; W Wechsler
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.